Drugs & medicalClass II

ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617,…

Subpotent

Read the official notice →
Date
2025-05-07
Country
United States
Brand
Accord Healthcare
Product
Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617,…
Classification
Class II
Units
Nationwide US.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Accord Healthcare recalls

  1. 2026-07-08
  2. US
  3. 2025-10-15
  4. US
    Drugs & medicalClass II

    ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh,…

    Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.

    FDA · DrugACCORD HEALTHCARE, INC.Nationwide in the USOfficial notice →
  5. 2025-07-23
  6. US
    Drugs & medicalClass II

    ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC…

    Subpotent Drug: Assay below the approved specification

    FDA · DrugACCORD HEALTHCARE, INC.Nationwide in the USAOfficial notice →
  7. 2024-12-11
  8. US
  9. 2024-11-06
  10. US
    Drugs & medicalClass II

    ACCORD HEALTHCARE, INC. recalls Cinacalcet Tablets, 90 mg, Rx Only, a) 30 Tablets per bottle, NDC: 16729-442-10, b) 90 Tablets per bottle, NDC: 16729-442-15,…

    CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

    FDA · DrugACCORD HEALTHCARE, INC.Nationwide in the USA and PROfficial notice →
  11. 2024-10-23
  12. US
    Drugs & medicalClass II

    ACCORD HEALTHCARE, INC. recalls Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: Accord Healthcare…

    Failed Impurities/Degradation Specifications.

    FDA · DrugACCORD HEALTHCARE, INC.Nationwide within the United States and PROfficial notice →
All 14 Accord Healthcare recalls →

Other drugs & medical recalls in the United States

  1. 2025-05-07
  2. US
    Drugs & medicalClass I

    GE Medical Systems China Co., Ltd. recalls GE Healthcare CARESTATION 620 A2, Model/REF Number 1012-9620-002. Anesthesia system.

    Certain Carestation 620/650/650c and 750/750c Anesthesia Delivery Systems will not provide effective ventilation in Volume Control Ventilation (VCV) mode. In these systems, effective ventilation can be achieved in…

    FDA · DeviceGE Medical Systems China Co., Ltd.Worldwide distribution. US nationwide including Puerto Rico, Albania, Algeria,…Official notice →
  3. US
    Drugs & medicalClass II

    Mckesson Medical-Surgical Inc. Corporate Office recalls Infuvite Adult, multiple vitamins injection, Baxter, Five of Vial 1 (5 mL) and Five of Vial 2 (5mL), Rx Only,…

    Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products…

    FDA · DrugMckesson Medical-Surgical Inc. Corporate OfficeDistributed to Medical Facilities in MS and FL.Official notice →
  4. US
    Drugs & medicalClass II

    American Regent, Inc. recalls niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, Mfd for: Civica, Inc., Lehi, UT…

    Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.

    FDA · DrugAmerican Regent, Inc.Nationwide in the USAOfficial notice →
  5. US
    Drugs & medicalClass II

    Cardinal Health Inc. recalls Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose…

    Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically,…

    FDA · DrugCardinal Health Inc.NC, SC, VAOfficial notice →
  6. US
    Drugs & medicalClass II

    Nubratori, Inc recalls Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12 - 5 mL Single Dose Units per box, Preservative…

    Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly…

    FDA · DrugNubratori, IncPA and CA.Official notice →
  7. US
See all drugs & medical recalls →